Kamada Ltd (KMDA)
Last updated: 2026-10-20 12:48:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Kamada Ltd (KMDA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $7.79, with a market capitalization of $447.83M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.55 to $9.35. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$447.83M | |
$7.62 | |
$17.95 | |
$3.02 | |
$7.61 | |
1.30K | |
123.00K | |
-- | |
$9.35 | |
$6.55 | |
-- | |
-- |
Kamada Ltd (KMDA) Pre-Market Stock Price
Kamada Ltd (KMDA) is trading at $7.79 in pre-market trading as of 2026-10-20 12:18:00, up 2.30% ($0.17) from the previous close of $7.61
Pre-market trading shows how investors are pricing KMDA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Kamada Ltd (KMDA) 7-Day Stock Price Change
Over the past seven days, Kamada Ltd (KMDA) moved from $8.08 to $7.79, representing a decline of 3.65% ($0.29).
The stock traded between $7.46 and $8.11 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 59.35 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
KMDA 52-Week Price Position
Position in Range: 44.1%
KMDA is currently trading at $7.79, placing it 44.1% of the way from its 52-week low of $6.55 to its 52-week high of $9.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Kamada Ltd (KMDA)?
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Kamada Ltd Information
| Employees | 462 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Kamada Ltd (KMDA) Stock on MEXC
Eligible investors can buy real shares of Kamada Ltd (KMDA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Kamada Ltd (KMDA) stock price today?
2.Is KMDA stock going up or down today?
3.What is KMDA pre-market price?
4.What is KMDA after-hours price?
5.Is KMDA stock trading now?
6.Where does KMDA sit relative to its 52-week high and low?
7.What sector is Kamada Ltd in?
8.What is Kamada Ltd's market capitalization and where is it listed?
9.How is KMDA valued in terms of P/E ratio and EPS?
10.Does Kamada Ltd pay a dividend?
Explore More US Stocks
Search Stocks
KMDA Stock Calculator
Estimate the value between KMDA shares and USD.
KMDA Shares to USD
1.00 KMDA shares = 7.785 USD
Calculations are estimates based on the latest available price and are for reference only.


